Katy Cooper
About
Katy Cooper is a scholar working on Oncology, Psychiatry and Mental health and Cancer Research.
According to data from OpenAlex, Katy Cooper has authored 86 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Psychiatry and Mental health and 11 papers in Cancer Research. Recurrent topics in Katy Cooper's work include Sexual function and dysfunction studies (9 papers), Complementary and Alternative Medicine Studies (8 papers) and Breast Cancer Treatment Studies (7 papers). Katy Cooper is often cited by papers focused on Sexual function and dysfunction studies (9 papers), Complementary and Alternative Medicine Studies (8 papers) and Breast Cancer Treatment Studies (7 papers). Katy Cooper collaborates with scholars based in United Kingdom, United States and Denmark. Katy Cooper's co-authors include Christopher Carroll, Andrew Booth, Clare Relton, Kate Thomas, Philip E. Harris, Paul Tappenden, Diana Papaioannou, Ron Akehurst, Matt Stevenson and Eva Kaltenthaler and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cochrane Database of Systematic Reviews and Journal of Clinical Epidemiology.
In The Last Decade
Katy Cooper
84 papers receiving 3.0k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Katy Cooper United Kingdom | 30 | 539 | 444 | 378 | 326 | 289 | 86 | 3.1k | ||
| Dietlind L. Wahner‐Roedler United States | 33 | 1.1k 2.0× | 304 0.7× | 378 1.0× | 332 1.0× | 215 0.7× | 131 | 3.8k | ||
| Michael Steiner United Kingdom | 36 | 490 0.9× | 271 0.6× | 361 1.0× | 84 0.3× | 146 0.5× | 200 | 4.7k | ||
| Rajesh Balkrishnan United States | 39 | 246 0.5× | 525 1.2× | 1.4k 3.6× | 507 1.6× | 184 0.6× | 195 | 6.9k | ||
| Alexander Tsertsvadze Canada | 35 | 181 0.3× | 348 0.8× | 752 2.0× | 360 1.1× | 175 0.6× | 80 | 4.1k | ||
| Sydne J Newberry United States | 33 | 163 0.3× | 392 0.9× | 555 1.5× | 281 0.9× | 154 0.5× | 103 | 5.5k | ||
| B O’Brien Australia | 32 | 271 0.5× | 140 0.3× | 691 1.8× | 195 0.6× | 105 0.4× | 107 | 4.1k | ||
| Elizabeth Williamson United Kingdom | 39 | 194 0.4× | 596 1.3× | 366 1.0× | 262 0.8× | 263 0.9× | 132 | 7.2k | ||
| Rosa Parisi United Kingdom | 18 | 262 0.5× | 257 0.6× | 229 0.6× | 239 0.7× | 50 0.2× | 56 | 4.0k | ||
| Rajesh Balkrishnan United States | 36 | 137 0.3× | 249 0.6× | 571 1.5× | 297 0.9× | 74 0.3× | 158 | 4.6k | ||
| David B. Preen Australia | 40 | 153 0.3× | 501 1.1× | 1.1k 2.9× | 346 1.1× | 206 0.7× | 312 | 5.8k |
Countries citing papers authored by Katy Cooper
Since
Specialization
Citations
This map shows the geographic impact of Katy Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katy Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katy Cooper more than expected).
Fields of papers citing papers by Katy Cooper
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Katy Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katy Cooper. The network helps show where Katy Cooper may publish in the future.
Co-authorship network of co-authors of Katy Cooper
This figure shows the co-authorship network connecting the top 25 collaborators of Katy Cooper. A scholar is included among the top collaborators of Katy Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katy Cooper. Katy Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Cooper, Katy, Munira Essat, S Harnan, et al.. (2025). Gene expression profiling tests to guide adjuvant chemotherapy decisions in lymph node-positive early breast cancer: a systematic review. Breast Cancer Research and Treatment. 210(2). 229–247.
2.
Cooper, Katy, Anthea Sutton, S Harnan, et al.. (2024). Systematic Review of Newborn Screening Programmes for Spinal Muscular Atrophy. International Journal of Neonatal Screening. 10(3). 49–49.
3.
Cooper, Katy, Anthea Sutton, S Harnan, et al.. (2024). Systematic Review of Presymptomatic Treatment for Spinal Muscular Atrophy. International Journal of Neonatal Screening. 10(3). 56–56.
4.
Essat, Munira, Katy Cooper, Alice Bessey, et al.. (2022). Diagnostic accuracy of conventional oral examination for detecting oral cavity cancer and potentially malignant disorders in patients with clinically evident oral lesions: Systematic review and meta‐analysis. Head & Neck. 44(4). 998–1013.
5.
Kearns, Benjamin, Katy Cooper, Martin Orr, et al.. (2022). The Incidence and Costs of Adverse Events Associated with Antidepressants: Results from a Systematic Review, Network Meta-Analysis and Multi-Country Economic Model. Neuropsychiatric Disease and Treatment. Volume 18. 1133–1143.
6.
Kearns, Benjamin, Katy Cooper, Anna Cantrell, & Chloe Thomas. (2021). Schizophrenia Treatment with Second-Generation Antipsychotics: A Multi-Country Comparison of the Costs of Cardiovascular and Metabolic Adverse Events and Weight Gain. Neuropsychiatric Disease and Treatment. Volume 17. 125–137.
7.
Murphy, Peter J., Sofia Dias, Robert Hodgson, et al.. (2021). Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework. Health Technology Assessment. 25(76). 1–228.
8.
Cooper, Katy, Paul Tappenden, Anna Cantrell, & Kate Ennis. (2020). A systematic review of meta-analyses assessing the validity of tumour response endpoints as surrogates for progression-free or overall survival in cancer. British Journal of Cancer. 123(11). 1686–1696.
9.
Thomas, Chloe, Alan Brennan, Edward Goka, et al.. (2020). What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluation. BMJ Open. 10(9). e037486–e037486.
10.
Pandor, Abdullah, Eva Kaltenthaler, Marrissa Martyn‐St James, et al.. (2019). Delphi consensus reached to produce a decision tool for SelecTing Approaches for Rapid Reviews (STARR). Journal of Clinical Epidemiology. 114. 22–29.
11.
James, Marrissa Martyn‐St, Katy Cooper, Shijie Ren, et al.. (2016). Phosphodiesterase Type 5 Inhibitors for Premature Ejaculation: A Systematic Review and Meta-analysis. European Urology Focus. 3(1). 119–129.
12.
Pickering, A, Katy Cooper, S Harnan, et al.. (2015). Impact of prehospital transfer strategies in major trauma and head injury. The Journal of Trauma: Injury, Infection, and Critical Care. 78(1). 164–177.
13.
Preston, Louise, Janette Turner, Andrew Booth, et al.. (2015). Is there a relationship between surgical case volume and mortality in congenital heart disease services? A rapid evidence review. BMJ Open. 5(12). e009252–e009252.
14.
James, Marrissa Martyn‐St, Katy Cooper, Eva Kaltenthaler, et al.. (2015). Tramadol for premature ejaculation: a systematic review and meta-analysis. BMC Urology. 15(1). 6–6.
15.
Chatters, Robin, et al.. (2015). Psychological and psychosocial interventions for cannabis cessation in adults: A systematic review. Addiction Research & Theory. 24(2). 93–110.
16.
Hutchinson, Allen, Joanne Coster, Katy Cooper, et al.. (2013). A structured judgement method to enhance mortality case note review: development and evaluation. BMJ Quality & Safety. 22(12). 1032–1040.
17.
Harris, Philip E., Katy Cooper, Clare Relton, & Kate Thomas. (2012). Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. International Journal of Clinical Practice. 66(10). 924–939.
18.
Cooper, Katy, Yang Meng, S Harnan, et al.. (2011). Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation. Health Technology Assessment. 15(4). iii–iv, 1.
19.
Hutchinson, Anne, Joanne Coster, Katy Cooper, et al.. (2010). Comparison of case note review methods for evaluating quality and safety in health care. Health Technology Assessment. 14(10). iii–iv, ix.
20.
Tappenden, Paul, R Jackson, Katy Cooper, et al.. (2009). Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation. Health Technology Assessment. 13(11). iii, ix–xii, 1.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Dietlind L. Wahner‐Roedler Breakdown of academic impact, for papers by Michael Steiner Breakdown of academic impact, for papers by Rajesh Balkrishnan Breakdown of academic impact, for papers by Alexander Tsertsvadze Breakdown of academic impact, for papers by Sydne J Newberry Breakdown of academic impact, for papers by B O’Brien Breakdown of academic impact, for papers by Elizabeth Williamson Breakdown of academic impact, for papers by Rosa Parisi Breakdown of academic impact, for papers by Rajesh Balkrishnan Breakdown of academic impact, for papers by David B. Preen